Analytics for Life Inc.

Analytics for Life Inc. develops the CorVista® System, a cloud-based, AI-powered point-of-care diagnostic platform for non-invasive detection of cardiovascular diseases, including coronary artery disease (CAD) and pulmonary hypertension (PH). The proprietary system acquires cardiac and hemodynamic waveform signals at the point of care and transmits them securely to a cloud platform for real-time analysis using machine-learned diagnostic models derived from over 3,300 physiological features. The analytical engine was developed from prospective clinical studies on 10,000+ patients and is supported by over 80 issued patents and 81 pending across 40 invention families. The system provides results within minutes without specialized personnel, contrast agents, or stress testing, enabling physicians to diagnose and direct patient care efficiently while reducing diagnostic delays and loss-to-follow-up. Designed for integration into any professional healthcare setting with WiFi or cellular access, CorVista addresses multiple cardiovascular disease assessments in a single test. The company's regulatory strategy and quality framework are led by experienced personnel with expertise in US, EU, and international medical device submissions. The platform leverages distributed high-compute elastic cloud infrastructure with secure, HIPAA-compliant system design.